Regulation of Renal Ouabain-Resistant Na⁺-ATPase by Leptin, Nitric Oxide, Reactive Oxygen Species, and Cyclic Nucleotides: Implications for Obesity-Associated Hypertension

References

• Proverbio F, Condrescu-Guidi M, Whittembury G. Ouabain-insensitive Na+ stimulation of an Mg2+-dependent ATPase in kidney tissue. Biochim Biophys Acta. 1975; 394: 281–292
   PubMed Web of Science ®Google Scholar
• Proverbio F, Proverbio T, Marin R. Na+-ATPase is a different entity from the (Na++ K+)-ATPase in rat kidney basolateral plasma membranes. Biochim Biophys Acta. 1986; 858: 202–205
   PubMed Web of Science ®Google Scholar
• Proverbio F, Marin R, Proverbio T. The ouabain-insensitive sodium pump. Comp Biochem Physiol A. 1991; 99: 279–283
   PubMed Web of Science ®Google Scholar
• Di Campo V, Henriquez LM, Proverbio T, Marin R, Proverbio F. Effect of a high Na+ diet on cell volume and Na+-stimulated ATPase activities of rat kidney membranes. FEBS Lett. 1990; 274: 96–98
   PubMed Web of Science ®Google Scholar
• Rangel LB, Lopes AG, Lara LS, Carvalho TL, Silva LV, Oliveira MM, Einicker-Lamas M, Vieyra A, Nogaroli L, Caruso-Neves C. PI-PLCβ is involved in the modulation of the proximal tubule Na+-ATPase by angiotensin II. Regul Pept. 2005; 127: 177–182
   PubMed Web of Science ®Google Scholar
• Caruso-Neves C, Lara LS, Rangel LB, Grossi AL, Lopes AG. Angiotensin-(1–7) modulates the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule. Biochim Biophys Acta. 2000; 1467: 189–197
   PubMed Web of Science ®Google Scholar
• Lopes AG, Soares AC, Santos DP, Fernandes MS, Leao-Ferreira LR, Quintana-Gomes E, Caruso-Neves C. PLA2/PGE2 are involved in the inhibitory effect of bradykinin on the angiotensin-(1–7)-stimulated Na+-ATPase activity of the proximal tubule. Regul Pept. 2004; 117: 37–41
   PubMed Web of Science ®Google Scholar
• Gomes CP, Leao-Ferreira LR, Caruso-Neves C, Lopes AG. Adenosine reverses the stimulatory effect of angiotensin II on the renal Na+-ATPase activity through the A2 receptor. Regul Pept. 2005; 129: 9–15
   PubMed Web of Science ®Google Scholar
• Féraille E, Doucet A. Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control. Physiol Rev. 2001; 81: 345–418
   PubMed Web of Science ®Google Scholar
• Nishi A, Eklof AC, Bertorello AM, Aperia A. Dopamine regulation of renal Na+, K+-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension. 1993; 21: 767–771
   PubMed Web of Science ®Google Scholar
• Nguyen AT, Hayward-Lester A, Sabatini S, Doris PA. Renal Na+, K+-ATPase in SHR: studies of activity and gene expression. Clin Exp Hypertens. 1998; 20: 641–656
   PubMed Web of Science ®Google Scholar
• Shah S, Hussain T. Enhanced angiotensin II-induced activation of Na+, K+-ATPase in the proximal tubules of obese Zucker rats. Clin Exp Hypertens. 2006; 28: 29–40
   PubMed Web of Science ®Google Scholar
• Pantanetti P, Garrapa GG, Mantero F, Boscaro M, Faloia E, Venarucci D. Adipose tissue as an endocrine organ? A review of recent data related to cardiovascular complications of endocrine dysfunctions. Clin Exp Hypertens. 2004; 26: 387–398
   PubMed Web of Science ®Google Scholar
• Beltowski J. Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens. 2006; 24: 789–801
   PubMed Web of Science ®Google Scholar
• Jackson EK, Li P. Human leptin has natriuretic activity in the rat. Am J Physiol. 1997; 272: F333–F338
   PubMed Web of Science ®Google Scholar
• Beltowski J, Wójcicka G, Górny D, Marciniak A. Human leptin administered intraperitoneally stimulates natriuresis and decreases renal medullary Na+, K+-ATPase activity in the rat—impaired effect in dietary-induced obesity. Med Sci Monit. 2002; 8: BR221–BR229
   PubMedGoogle Scholar
• Beltowski J, Jamroz-Wisniewska A, Borkowska E, Wójcicka G. Up-regulation of renal Na+, K+-ATPase: the possible novel mechanism of leptin-induced hypertension. Pol. J. Pharmacol. 2004; 56: 213–222
   PubMedGoogle Scholar
• Marciniak A, Jamroz-Wisniewska A, Borkowska E, Beltowski J. Time-dependent effect of leptin on renal Na+, K+-ATPase activity. Acta Biochim Pol. 2005; 52: 803–809
   PubMed Web of Science ®Google Scholar
• Beltowski J, Jamroz-Wisniewska A, Nazar J, Wójcicka G. Spectrophotometric assay of renal ouabain-resistant Na+-ATPase and its regulation by leptin and dietary-induced obesity. Acta Biochim Pol. 2004; 51: 1003–1014
   PubMed Web of Science ®Google Scholar
• Beltowski J, Marciniak A, Wójcicka G. Leptin decreases renal medullary Na+, K+-ATPase activity through phosphatidylinositol 3-kinase dependent mechanism. J Physiol Pharmacol. 2004; 55: 391–407
   PubMed Web of Science ®Google Scholar
• Hurst RO. The determination of nucleotide phosphorus with a stannous chloride-hydrazine sulphate reagent. Can J Biochem. 1964; 42: 287–292
   PubMedGoogle Scholar
• Lowry OH, Rosenbrough NI, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Beltowski J, Jamroz-Wisniewska A, Borkowska E, Nazar J, Marciniak A. Antioxidant treatment normalizes renal Na+, K+-ATPase activity in leptin-treated rats. Pharmacol Rep. 2005; 57: 219–228
   PubMed Web of Science ®Google Scholar
• Beltowski J, Marciniak A, Jamroz-Wisniewska A, Borkowska E. Nitric oxide—superoxide cooperation in the regulation of renal Na+, K+-ATPase. Acta Biochim. Pol. 2004; 51: 933–942
   PubMed Web of Science ®Google Scholar
• Beltowski J, Marciniak A Wójcicka G, Górny D. Nitric oxide decreases renal medullary Na+, K+-ATPase activity through cyclic GMP-protein kinase G dependent mechanism. J Physiol Pharmacol. 2003; 54: 191–210
   PubMed Web of Science ®Google Scholar
• Burkhardt M, Glazova M, Gambaryan S, Vollkommer T, Butt E, Bader B, Heermeier K, Lincoln TM, Walter U, Palmetshofer A. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem. 2000; 275: 33536–33541
   PubMed Web of Science ®Google Scholar
• Dousa TP. Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int. 1999; 55: 29–62
   PubMed Web of Science ®Google Scholar
• Caruso-Neves C, Rangel LB, Vives D, Vieyra A, Coka-Guevara S, Lopes AG. Ouabain-insensitive Na+-ATPase activity is an effector protein for cAMP regulation in basolateral membranes of the proximal tubule. Biochim Biophys Acta. 2000; 1468: 107–114
   PubMed Web of Science ®Google Scholar
• Lara Lda S, Cavalcante F, Axelband F, De Souza AM, Lopes AG, Caruso-Neves C. Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1–7). Biochem. J. 2006; 395: 183–190
   PubMed Web of Science ®Google Scholar
• Caruso-Neves C, Vives D, Dantas C, Albino CM, Fonseca LM, Lara LS, Iso M, Lopes AG. Ouabain-insensitive Na+-ATPase of proximal tubules is an effector for urodilatin and atrial natriuretic peptide. Biochim Biophys Acta. 2004; 1660: 93–98
   PubMed Web of Science ®Google Scholar
• Su J, Scholz PM, Weiss HR. Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes. Exp Biol Med. 2005; 230: 242–250
   PubMed Web of Science ®Google Scholar
• Rivero-Vilches FJ, de Frutos S, Saura M, Rodriguez-Puyol D, Rodriguez-Puyol M. Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I α activation by NO/cGMP. Am J Physiol Cell Physiol. 2003; 285: C891–C898
   PubMed Web of Science ®Google Scholar
• Castro LR, Verde I, Cooper DM, Fischmeister R. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes. Circulation. 2006; 113: 2221–2228
   PubMed Web of Science ®Google Scholar
• Gambaryan S, Hausler C, Markert T, Pohler D, Jarchau T, Walter U, Haase W, Kurtz A, Lohmann SM. Expression of type II cGMP-dependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression. J Clin. Invest. 1996; 98: 662–670
   PubMed Web of Science ®Google Scholar
• Beavo J. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev. 1995; 75: 725–748
   PubMed Web of Science ®Google Scholar
• Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev. 2000; 52: 375–414
   PubMed Web of Science ®Google Scholar
• Ortiz PA, Garvin JL. NO inhibits NaCl absorption by rat thick ascending limb through activation of cGMP-stimulated phosphodiesterases. Hypertension. 2001; 37: 467–471
   PubMed Web of Science ®Google Scholar
• Garcia NH, Stoos BA, Carretero OA, Garvin JL. Mechanism of the nitric oxide-induced blockade of collecting duct water permeability. Hypertension. 1996; 27: 679–683
   PubMed Web of Science ®Google Scholar
• Zou AP, Li N, Cowley AW. Production and actions of superoxide in the renal medulla. Hypertension. 2001; 37: 547–553
   PubMed Web of Science ®Google Scholar
• Li N, Yi FX, Spurrier JL, Bobrowitz CA, Zou AP. Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney. Am J Physiol Renal Physiol. 2002; 282: F1111–F1119
   PubMed Web of Science ®Google Scholar
• Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?. Am J Physiol Regulatory Integrative Comp Physiol. 2005; 289: R913–R935
   PubMed Web of Science ®Google Scholar
• Herrera M, Ortiz PA, Garvin JL. Regulation of thick ascending limb transport: role of nitric oxide. Am J Physiol Renal Physiol. 2006; 290: F1279–F1284
   PubMed Web of Science ®Google Scholar
• Makino A, Skelton MM, Zou AP, Roman RJ, Cowley AW. Increased renal medullary oxidative stress produces hypertension. Hypertension. 2002; 39: 667–672
   PubMed Web of Science ®Google Scholar
• Juncos R, Garvin JL. Superoxide enhances Na-K-2Cl cotransporter activity in the thick ascending limb. Am J Physiol Renal Physiol. 2005; 288: F982–F987
   PubMed Web of Science ®Google Scholar
• Shokoji T, Fujisawa Y, Kimura S, Rahman M, Kiyomoto H, Matsubara K, Moriwaki K, Aki Y, Miyatake A, Kohno M, Abe Y, Nishiyama A. Effects of local administrations of tempol and diethyldithio-carbamic on peripheral nerve activity. Hypertension. 2004; 44: 236–243
   PubMed Web of Science ®Google Scholar
• Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism. 2006; 55: 928–934
   PubMed Web of Science ®Google Scholar
• Banday AA, Marwaha A, Tallam LS, Lokhandwala MF. Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats. Diabetes. 2005; 54: 2219–2226
   PubMed Web of Science ®Google Scholar
• Villarreal D, Reams G, Samar H, Spear R, Freeman RH. Effects of chronic nitric oxide inhibition on the renal excretory response to leptin. Obes. Res. 2004; 12: 1006–1010
   PubMedGoogle Scholar
• Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2005; 45: 9–14
   PubMed Web of Science ®Google Scholar
• Li L, Mamputu JC, Wiernsperger N, Renier G. Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes. 2005; 54: 2227–2234
   PubMed Web of Science ®Google Scholar
• Dong F, Zhang X, Ren J. Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway. Hypertension. 2006; 47: 222–229
   PubMed Web of Science ®Google Scholar
• Gunduz Z, Dursun N, Akgun H, Ozturk F, Okur H, Koc N. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats. Regul. Pept. 2005; 132: 59–66
   PubMed Web of Science ®Google Scholar
• Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998; 31: 409–414
   PubMed Web of Science ®Google Scholar
• Kuo JJ, Jones OB, Hall JE. Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension. 2001; 37: 670–676
   PubMed Web of Science ®Google Scholar
• El-Gharbawy AH, Kotchen JM, Grim CE, Kaldunski M, Hoffmann RG, Pausova Z, Hamet P, Kotchen TA. Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans. Am J Hypertens. 2002; 15: 989–993
   PubMed Web of Science ®Google Scholar
• Marciniak A, Borkowska E, Kedra A, Rychlik M, Beltowski J. Time-dependent transition from H2O2-ERK to O2−-NO dependent mechanism in the stimulatory effect of leptin on renal Na+, K+-ATPase in the rat. Clin Exp Pharmacol Physiol. 2006; 33: 1216–1224
   PubMed Web of Science ®Google Scholar